Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| JELD-WEN Holding, Inc.JELD · Entity 6378 | EVP & President, Australasia | August 06, 2021 | August 10, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
JELD-WEN Holding, Inc.
Report date August 06, 2021 · Filed August 10, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 216,126 |
Reported balance
After 2021-08-06 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2021-08-06 · Exercise / conversion · Acquired 52,240 · Balance 216,126 |
| Common StockSEC Table I · non-derivative | Direct | 226,686 |
Reported balance
After 2021-08-06 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2021-08-06 · Exercise / conversion · Acquired 10,560 · Balance 226,686 |
| Common StockSEC Table I · non-derivative | Direct | 239,746 |
Reported balance
After 2021-08-06 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2021-08-06 · Exercise / conversion · Acquired 13,060 · Balance 239,746 |
| Common StockSEC Table I · non-derivative | Direct | 243,266 |
Reported balance
After 2021-08-06 transaction · row 4
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 4 · 2021-08-06 · Exercise / conversion · Acquired 3,520 · Balance 243,266 |
| Common StockSEC Table I · non-derivative | Direct | 246,786 |
Reported balance
After 2021-08-09 transaction · row 5
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 5 · 2021-08-09 · Exercise / conversion · Acquired 3,520 · Balance 246,786 |
| Common StockSEC Table I · non-derivative | Direct | 256,697 |
Reported balance
After 2021-08-09 transaction · row 6
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 6 · 2021-08-09 · Exercise / conversion · Acquired 9,911 · Balance 256,697 |
| Common StockSEC Table I · non-derivative | Direct | 193,897 |
Reported balance
After 2021-08-06 transaction · row 7
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 7 · 2021-08-06 · Sale · Disposed 62,800 · Balance 193,897 F1: Certain shares sold by the reporting person to cover tax obligation associated with the vesting of an RSU award on August 6, 2021. F2: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.87 to $28.30 per share, inclusive. The reporting person undertakes to provide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 188,897 |
Reported balance
After 2021-08-06 transaction · row 8
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 8 · 2021-08-06 · Sale · Disposed 5,000 · Balance 188,897 F1: Certain shares sold by the reporting person to cover tax obligation associated with the vesting of an RSU award on August 6, 2021. F3: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.18 to $28.19 per share, inclusive. The reporting person undertakes to provide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 172,317 |
Reported balance
After 2021-08-06 transaction · row 9
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 9 · 2021-08-06 · Sale · Disposed 16,580 · Balance 172,317 F1: Certain shares sold by the reporting person to cover tax obligation associated with the vesting of an RSU award on August 6, 2021. F4: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.13 to $28.08 per share, inclusive. The reporting person undertakes to provide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 158,886 |
Reported balance
After 2021-08-09 transaction · row 10
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 10 · 2021-08-09 · Sale · Disposed 13,431 · Balance 158,886 F1: Certain shares sold by the reporting person to cover tax obligation associated with the vesting of an RSU award on August 6, 2021. F5: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.75 to $27.97 per share, inclusive. The reporting person undertakes toprovide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price within the range set forth in this footnote. |
| Common StockSEC Table I · non-derivative | Direct | 133,836 |
Reported balance
After 2021-08-09 transaction · row 11
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 11 · 2021-08-09 · Sale · Disposed 25,050 · Balance 133,836 F1: Certain shares sold by the reporting person to cover tax obligation associated with the vesting of an RSU award on August 6, 2021. F6: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.75 to $27.98 per share, inclusive. The reporting person undertakes toprovide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price within the range set forth in this footnote. |
| Common Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.74 · Expires 2024-05-02 | Direct | 0 |
Reported balance
After 2021-08-06 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2021-08-06 · Exercise / conversion · Disposed 52,240 · Balance 0 F7: This option is fully vested as of May 2, 2019. |
| Common Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.97 · Expires 2024-05-02 | Direct | 0 |
Reported balance
After 2021-08-06 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2021-08-06 · Exercise / conversion · Disposed 10,560 · Balance 0 F7: This option is fully vested as of May 2, 2019. |
| Common Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.76 · Expires 2024-05-02 | Direct | 0 |
Reported balance
After 2021-08-06 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2021-08-06 · Exercise / conversion · Disposed 13,060 · Balance 0 F8: This option is fully vested as of May 2, 2015. |
| Common Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.07 · Expires 2024-05-02 | Direct | 0 |
Reported balance
After 2021-08-06 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2021-08-06 · Exercise / conversion · Disposed 3,520 · Balance 0 F9: This option is fully vested as of May 2, 2016. |
| Common Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.79 · Expires 2024-05-02 | Direct | 0 |
Reported balance
After 2021-08-09 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2021-08-09 · Exercise / conversion · Disposed 3,520 · Balance 0 F8: This option is fully vested as of May 2, 2015. |
| Common Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.96 · Expires 2029-02-25 | Direct | 0 |
Reported balance
After 2021-08-09 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2021-08-09 · Exercise / conversion · Disposed 9,911 · Balance 0 F10: This option is vested with respect to 15,006 underlying shares and will vest with respect to the remaining 7,503 underlying shares on February 25, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Certain shares sold by the reporting person to cover tax obligation associated with the vesting of an RSU award on August 6, 2021.
F2: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.87 to $28.30 per share, inclusive. The reporting person undertakes to provide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price within the range set forth in this footnote.
F3: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.18 to $28.19 per share, inclusive. The reporting person undertakes to provide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.13 to $28.08 per share, inclusive. The reporting person undertakes to provide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.75 to $27.97 per share, inclusive. The reporting person undertakes toprovide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price within the range set forth in this footnote.
F6: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.75 to $27.98 per share, inclusive. The reporting person undertakes toprovide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price within the range set forth in this footnote.
F7: This option is fully vested as of May 2, 2019.
F8: This option is fully vested as of May 2, 2015.
F9: This option is fully vested as of May 2, 2016.
F10: This option is vested with respect to 15,006 underlying shares and will vest with respect to the remaining 7,503 underlying shares on February 25, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | Exercise / conversionCommon Stock Option (Right to Buy) · Derivative | 9,911 | $0.00 Strike: $20.96 | $0.00 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · derivative · entry 17 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,911 shares Expires 2029-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: This option is vested with respect to 15,006 underlying shares and will vest with respect to the remaining 7,503 underlying shares on February 25, 2022. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | Exercise / conversionCommon Stock Option (Right to Buy) · Derivative | 3,520 | $0.00 Strike: $18.79 | $0.00 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · derivative · entry 16 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,520 shares Expires 2024-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option is fully vested as of May 2, 2015. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | SaleCommon Stock | 25,050 | $27.86 | $697,973.16 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · nonDerivative · entry 11 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,836 F1 · shares: Certain shares sold by the reporting person to cover tax obligation associated with the vesting of an RSU award on August 6, 2021. F6 · price: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.75 to $27.98 per share, inclusive. The reporting person undertakes toprovide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | SaleCommon Stock | 13,431 | $27.84 | $373,909.64 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · nonDerivative · entry 10 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,886 F1 · shares: Certain shares sold by the reporting person to cover tax obligation associated with the vesting of an RSU award on August 6, 2021. F5 · price: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.75 to $27.97 per share, inclusive. The reporting person undertakes toprovide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price within the range set forth in this footnote. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | Exercise / conversionCommon Stock | 9,911 | $20.96 | $207,734.56 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · nonDerivative · entry 6 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | Exercise / conversionCommon Stock | 3,520 | $18.79 | $66,140.80 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · nonDerivative · entry 5 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | Exercise / conversionCommon Stock Option (Right to Buy) · Derivative | 3,520 | $0.00 Strike: $14.07 | $0.00 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · derivative · entry 15 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,520 shares Expires 2024-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: This option is fully vested as of May 2, 2016. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | Exercise / conversionCommon Stock Option (Right to Buy) · Derivative | 13,060 | $0.00 Strike: $10.76 | $0.00 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · derivative · entry 14 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,060 shares Expires 2024-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option is fully vested as of May 2, 2015. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | Exercise / conversionCommon Stock Option (Right to Buy) · Derivative | 10,560 | $0.00 Strike: $9.97 | $0.00 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · derivative · entry 13 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,560 shares Expires 2024-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option is fully vested as of May 2, 2019. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | Exercise / conversionCommon Stock Option (Right to Buy) · Derivative | 52,240 | $0.00 Strike: $6.74 | $0.00 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · derivative · entry 12 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,240 shares Expires 2024-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option is fully vested as of May 2, 2019. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | SaleCommon Stock | 16,580 | $28.09 | $465,778.62 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · nonDerivative · entry 9 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,317 F1 · shares: Certain shares sold by the reporting person to cover tax obligation associated with the vesting of an RSU award on August 6, 2021. F4 · price: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.13 to $28.08 per share, inclusive. The reporting person undertakes to provide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | SaleCommon Stock | 5,000 | $28.13 | $140,673.00 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · nonDerivative · entry 8 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,897 F1 · shares: Certain shares sold by the reporting person to cover tax obligation associated with the vesting of an RSU award on August 6, 2021. F3 · price: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.18 to $28.19 per share, inclusive. The reporting person undertakes to provide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | SaleCommon Stock | 62,800 | $28.00 | $1,758,632.36 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · nonDerivative · entry 7 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,897 F1 · shares: Certain shares sold by the reporting person to cover tax obligation associated with the vesting of an RSU award on August 6, 2021. F2 · price: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.87 to $28.30 per share, inclusive. The reporting person undertakes to provide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares soldat each separate price within the range set forth in this footnote. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | Exercise / conversionCommon Stock | 3,520 | $14.07 | $49,526.40 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · nonDerivative · entry 4 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | Exercise / conversionCommon Stock | 13,060 | $10.76 | $140,525.60 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · nonDerivative · entry 3 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | Exercise / conversionCommon Stock | 10,560 | $9.97 | $105,283.20 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · nonDerivative · entry 2 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,686 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2021 Filed Aug 10, 2021 21:12 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | Exercise / conversionCommon Stock | 52,240 | $6.74 | $352,097.60 |
DisclosureSEC source: 0001674335-21-000092 · wf-form4_162864435873785.xml · nonDerivative · entry 1 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 16:49 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | SaleCommon Stock | 5,336 | $28.51 | $152,129.36 |
DisclosureSEC source: 0001674335-21-000078 · wf-form4_162275331672891.xml · nonDerivative · entry 1 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,886 F1 · price: The reported price in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.49 to $28.53 per share, inclusive. The reporting person undertakes to provide to JELD-WEN Holding, Inc., any security holder of JELD-WEN Holding, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 23, 2021 Filed Mar 2, 2021 17:36 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | GrantCommon Stock Option (Right to Buy) · Derivative | 17,865 | $0.00 Strike: $29.01 | $0.00 |
DisclosureSEC source: 0001674335-21-000022 · wf-form4_161472456612536.xml · derivative · entry 2 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,865 Underlying: Common Stock · 17,865 shares Expires 2031-02-23 F2 · derivative.exercise_date: Subject to the reporting person's continued employment with the issuer, the options will vest ratably on each of the first three anniversaries of the grant date. Read SEC document |
| February 23, 2021 Filed Mar 2, 2021 17:36 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | GrantCommon Stock | 8,861 | $0.00 | $0.00 |
DisclosureSEC source: 0001674335-21-000022 · wf-form4_161472456612536.xml · nonDerivative · entry 1 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,222 F1 · shares: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer, these restricted stock units will vest ratably on each of the first three anniversaries of the grant date. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 20:02 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | GrantCommon Stock Option (Right to Buy) · Derivative | 16,343 | $24.54 Strike: $24.54 | $401,057.22 |
DisclosureSEC source: 0001674335-20-000016 · wf-form4_158164213615033.xml · derivative · entry 2 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,343 Underlying: Common Stock · 16,343 shares Expires 2030-02-11 F2 · derivative.exercise_date: Subject to the reporting person's continued employment with the issuer, the options will vest ratably on February 11, 2021, February 11, 2022 and February 11, 2023. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 20:02 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | GrantCommon Stock | 6,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001674335-20-000016 · wf-form4_158164213615033.xml · nonDerivative · entry 1 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,361 F1 · security: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer, these restricted stock units will vest on February 11, 2023. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 16:42 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | GrantCommon Stock | 75,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001674335-19-000074 · wf-form4_156529693131110.xml · nonDerivative · entry 1 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,068 F1 · shares: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer, these restricted stock units will vest ratably on August 6, 2021, August 6, 2022 and August 6, 2023. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 18:23 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | GrantCommon Stock · Derivative | 22,509 | $20.96 Strike: $20.96 | $471,788.64 |
DisclosureSEC source: 0001674335-19-000014 · wf-form4_155130978216414.xml · derivative · entry 3 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,509 Underlying: Common Stock · 22,509 shares Expires 2029-02-25 F3 · derivative.exercise_date: Subject to the reporting person's continued employment with the issuer, the options will vest ratably on February 25, 2020, February 25, 2021 and February 25, 2022. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 18:23 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | GrantCommon Stock | 59,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001674335-19-000014 · wf-form4_155130978216414.xml · nonDerivative · entry 2 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,918 F2 · security: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer, these restricted stock units will vest ratably on February 25, 2022 and February 25, 2023. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 18:23 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | GrantCommon Stock | 8,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001674335-19-000014 · wf-form4_155130978216414.xml · nonDerivative · entry 1 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,281 F1 · security: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer, these restricted stock units will vest on February 25, 2022. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 20:10 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | GrantStock Option (Right to Buy) · Derivative | 9,281 | $0.00 Strike: $33.34 | $0.00 |
DisclosureSEC source: 0001674335-18-000013 · wf-form4_151986660519482.xml · derivative · entry 2 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,281 Underlying: Common Stock · 9,281 shares Expires 2028-02-26 F2 · derivative.exercise_date: Subject to the reporting person's continued employment with the issuer, the options will vest ratably on February 26, 2019, February 26, 2020 and February 26, 2021. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 20:10 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | GrantCommon Stock | 3,615 | $0.00 | $0.00 |
DisclosureSEC source: 0001674335-18-000013 · wf-form4_151986660519482.xml · nonDerivative · entry 1 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,336 F1 · security: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer, these restricted stock units will vest on February 26, 2021. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 16:32 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | GrantStock Option (Right to Buy) · Derivative | 23,096 | $0.00 Strike: $27.59 | $0.00 |
DisclosureSEC source: 0001140361-17-004573 · doc1.xml · derivative · entry 2 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,096 Underlying: Common Stock · 23,096 shares Expires 2027-02-02 F2 · derivative.exercise_date: Subject to the reporting person's continued employment with the issuer, these options will vest ratably on February 2, 2018, February 2, 2019 and February 2, 2020. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 16:32 UTC | JELD-WEN Holding, Inc. JELD · Entity 6378 | GrantCommon Stock | 6,721 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-004573 · doc1.xml · nonDerivative · entry 1 Farmakis Peter · CIK 0001695321 · EVP & President, Australasia 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,721 F1 · security: The reported transaction is an award of restricted stock units in respect of the issuer's common stock. Subject to the reporting person's continued employment with the issuer, these restricted stock units will vest on February 2, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.